Author:
Roden Anja C.,Tazelaar Henry D.
Publisher
Springer Berlin Heidelberg
Reference148 articles.
1. Aharinejad, S., Taghavi, S., Klepetko, W., et al.: Prediction of lung-transplant rejection by hepatocyte growth factor. Lancet 363, 1503–1508 (2004)
2. Amital, A., Shitrit, D., Raviv, Y., et al.: Development of malignancy following lung transplantation. Transplantation 81, 547–551 (2006)
3. Appel 3rd, J.Z., Hartwig, M.G., Davis, R.D., et al.: Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Hum. Immunol. 66, 378–386 (2005)
4. Armitage, J.M., Kormos, R.L., Stuart, R.S., et al.: Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J. Heart Lung Transplant. 10, 877–886 (1991); discussion 886–877
5. Assi, M.A., Pulido, J.S., Peters, S.G., et al.: Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin. Transplant. 21, 1–6 (2007)